mesalamine has been researched along with Shock, Cardiogenic in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fleming, K | 1 |
| Ashcroft, A | 1 |
| Alexakis, C | 1 |
| Tzias, D | 1 |
| Groves, C | 1 |
| Poullis, A | 1 |
1 other study available for mesalamine and Shock, Cardiogenic
| Article | Year |
|---|---|
Proposed case of mesalazine-induced cardiomyopathy in severe ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cardiomyopathies; Colitis, Ulcerative; Drug Substitu | 2015 |